[HTML][HTML] 施用抗抑鬱藥草酸依他普侖治療馬來西亞病人的強迫症
A Hatim, JS Gill, ST Jambunathan, TH Yen, M Ariff… - easap.asia
… treatment-emergent adverse events was comparable in the 2 … One of the major causes
being genetic polymorphism of drug… : CYP2C19, CYP2D6, and CYP3A4. The incidence of …
being genetic polymorphism of drug… : CYP2C19, CYP2D6, and CYP3A4. The incidence of …
他克莫司血药浓度及相关基因多态性与心脏移植术后新发糖尿病的相关性
张敏， 蔡杰， 张菁， 袁拥华， 韩勇， 周红 - 医药导报, 2020 - yydbzz.com
… trough concentrations and genetic polymorphisms and new … and on transplant-related
adverse events are limited.Methods … of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on …
adverse events are limited.Methods … of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on …
撤市药物的遗传药理学
陈旺青， 张伟 - 中国临床药理学与治疗学, 2011 - manu41.magtech.com.cn
… 那定同时服用CYP3A4 抑制剂或 者因为CYP3A4 个体差异, 导致… Genetic polymorphisms
and the cardiovascular risk of non… withdrawn from the market were often of serious adverse …
and the cardiovascular risk of non… withdrawn from the market were often of serious adverse …
基因多型性及臨床因素對腎臟移植病人tacrolimus 血中濃度之影響
温俊銘 - 2018 - tdr.lib.ntu.edu.tw
… In contrast, 92.2 % of CYP3A5 nonexpressers did not have CYP3A4*1G mutation. CYP3A4*1G
polymorphism was strongly linked with the CYP3A5*3 polymorphism. Last but not least, …
polymorphism was strongly linked with the CYP3A5*3 polymorphism. Last but not least, …
[HTML][HTML] 质子泵抑制剂的应用与发展
周洁浩， 刘冰熔 - 世界华人消化杂志, 2013 - wjgnet.com
… with regard to the mechanism of action, side effects, and interactions with other drugs and
… , 包括CYP3A4,CYP3A5,CYP2D6,CYP2C9,CYP2C19等. 其中与PPIs代谢有关的是CYP3A4与…
… , 包括CYP3A4,CYP3A5,CYP2D6,CYP2C9,CYP2C19等. 其中与PPIs代谢有关的是CYP3A4与…
天然素材Tryptanthrin 對隱球菌的抗菌效果及細胞週期之影響
張雅琳 - 2018 - tdr.lib.ntu.edu.tw
… that ideally will reduce the occurrence of adverse effects associated with the original
formulations.The newest antifungal drug, isavuconazonium sulfate, is now commercially available …
formulations.The newest antifungal drug, isavuconazonium sulfate, is now commercially available …
[PDF][PDF] 利培酮相关横纹肌溶解症的临床特点分析
李佐军， 苏彦红， 周于禄， 吴翠芳， 王春江 - 药物不良反应杂志, 2022 - cadrj.com
… hallucinations induced by drug withdrawal after taking the … 利培酮与他汀类药 物通过
CYP3A4 竞争机制性升高了辛伐他汀… Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): …
CYP3A4 竞争机制性升高了辛伐他汀… Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): …
Cladribine 用於多發性硬化症之治療
林柏勝， 莊美華 - 臺灣臨床藥學雜誌, 2019 - airitilibrary.com
… 有超過200 個基因多型性(genetic polymorphisms) 與罹患風險有關,其中以HLA DRB1*1501 …
,CYP2E1 及 CYP3A4,皆不影響藥物動力學.本身也不會誘 導CYP1A2,CYP2B6 及CYP3A4 酵素.…
,CYP2E1 及 CYP3A4,皆不影響藥物動力學.本身也不會誘 導CYP1A2,CYP2B6 及CYP3A4 酵素.…
[PDF][PDF] 新型冠状病毒肺炎患者药物性肝损伤发生情况及其危险因素分析
邓轩宇， 黄娟娟， 孙吉， 黄师琼， 李燕飞， 何鸽飞 - 药物不良反应杂志, 2020 - cadrj.com
… liver‑protective treatments without drug withdrawal. Among the 36 … 队列研究结果显示,使用
经肝 脏CYP3A4 代谢的洛匹那韦/利托… Progress in genetic polymorphism of cytochrome P450 …
经肝 脏CYP3A4 代谢的洛匹那韦/利托… Progress in genetic polymorphism of cytochrome P450 …